Apollo Hospitals has reported robust financial results for FY26, marked by sustained growth across all business verticals. The company achieved consolidated revenue of ₹25,229 crore, a 16% YoY growth, and a 34% YoY increase in PAT to ₹1,942 crore. The Board has recommended a final dividend of ₹10 per equity share, reflecting strong operational performance, significant clinical excellence, and continued momentum in both healthcare services and the digital health ecosystem.
Financial Performance Highlights
For the fiscal year ended March 31, 2026, Apollo Hospitals delivered strong results. Consolidated revenue grew by 16% YoY to ₹25,229 crore. The consolidated EBITDA reached ₹3,769 crore, showing a 25% YoY increase, while the consolidated Profit After Tax (PAT) surged by 34% YoY to ₹1,942 crore. The Board of Directors has recommended a final dividend of ₹10 per equity share for the FY2025-26 period.
Strategic Business Developments
A key strategic move involves a transaction between Apollo Health and Lifestyle Limited (AHLL) and Kids Clinic India Limited (Cloudnine). AHLL will divest its stake in its maternity and fertility business to Cloudnine at an enterprise value of ₹1,550 crore, receiving a mix of cash and a 9.9% equity stake in the combined entity. This move aims to create one of India’s largest integrated maternity and fertility care platforms.
Operational Expansion and Growth
Apollo Hospitals continues to scale its operations with the commissioning of a new 400-bedded smart hospital in the Financial District, Hyderabad, and a new 270-bed facility in Sonarpur, Kolkata. The company’s expansion plans remain robust, having launched four hospitals over the past six months, bringing the total network to over 10,900 beds across 78 hospitals.
Leadership and Corporate Governance
The Board has approved the re-appointment of Dr. Prathap C Reddy as Executive Chairman for a period of two years effective June 25, 2026. Additionally, the proposal for the merger of Apollo Hospitals North Limited into the holding company was approved to consolidate operations and optimize costs. The Annual General Meeting is scheduled for August 25, 2026, with a record date of August 14, 2026, for both the final dividend and meeting attendance.
Source: BSE
